2022 Q1 Form 10-Q Financial Statement

#000095017022009646 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $139.6M $81.71M
YoY Change 70.82%
Cash & Equivalents $139.6M $81.71M
Short-Term Investments
Other Short-Term Assets $5.504M $6.205M
YoY Change -11.3%
Inventory $3.890M $979.0K
Prepaid Expenses $4.641M
Receivables $15.25M $2.577M
Other Receivables $0.00 $0.00
Total Short-Term Assets $190.1M $91.47M
YoY Change 107.84%
LONG-TERM ASSETS
Property, Plant & Equipment $9.411M $10.30M
YoY Change -8.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $849.0K $2.354M
YoY Change -63.93%
Total Long-Term Assets $19.28M $12.65M
YoY Change 52.36%
TOTAL ASSETS
Total Short-Term Assets $190.1M $91.47M
Total Long-Term Assets $19.28M $12.65M
Total Assets $209.4M $104.1M
YoY Change 101.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.184M $2.436M
YoY Change 194.91%
Accrued Expenses $15.13M $5.760M
YoY Change 162.71%
Deferred Revenue $35.63M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $58.79M $29.97M
YoY Change 96.15%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $28.08M
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $28.08M
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $58.79M $29.97M
Total Long-Term Liabilities $0.00 $28.08M
Total Liabilities $82.79M $58.05M
YoY Change 42.62%
SHAREHOLDERS EQUITY
Retained Earnings -$328.7M
YoY Change
Common Stock $24.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $126.6M -$177.4M
YoY Change
Total Liabilities & Shareholders Equity $209.4M $104.1M
YoY Change 101.09%

Cashflow Statement

Concept 2022 Q1 2021 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8154000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
862000
CY2021Q4 bgry Accrued Materials Current
AccruedMaterialsCurrent
3094000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2034000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1437000
CY2022Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
380000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
452000
CY2021Q1 us-gaap Line Of Credit Assumed1
LineOfCreditAssumed1
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001824734
CY2021Q1 bgry Right Of Use Asset Non Cash And Non Financing Activities
RightOfUseAssetNonCashAndNonFinancingActivities
CY2021Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39768
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Berkshire Grey, Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2994421
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
140 South Road
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Bedford
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01730
CY2022Q1 dei City Area Code
CityAreaCode
833
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
848-9900
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
139581000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
171089000
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15253000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13291000
CY2022Q1 us-gaap Inventory Net
InventoryNet
3890000
CY2021Q4 us-gaap Inventory Net
InventoryNet
2641000
CY2022Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
21241000
CY2021Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
7689000
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4641000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5138000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
5504000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5078000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
190110000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
204926000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9411000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10874000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
862000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
849000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22000
CY2022Q1 us-gaap Assets
Assets
209386000
CY2021Q4 us-gaap Assets
Assets
216684000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7184000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6766000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15132000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15659000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
35633000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19216000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
838000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
146000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
58787000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
41787000
CY2022Q1 us-gaap Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent
8482000
CY2021Q4 us-gaap Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent
15435000
CY2022Q1 bgry Warrant Liability
WarrantLiability
6093000
CY2021Q4 bgry Warrant Liability
WarrantLiability
13277000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9429000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1954000
CY2022Q1 us-gaap Liabilities
Liabilities
82791000
CY2021Q4 us-gaap Liabilities
Liabilities
72453000
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
24000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
24000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
455244000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
449307000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-328650000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-305084000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-23000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
126595000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
144231000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
209386000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
216684000
CY2022Q1 us-gaap Revenues
Revenues
5492000
CY2021Q1 us-gaap Revenues
Revenues
3965000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
6696000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
4698000
CY2022Q1 us-gaap Gross Profit
GrossProfit
-1204000
CY2021Q1 us-gaap Gross Profit
GrossProfit
-733000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7662000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4143000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1489000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27483000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20343000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12310000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
29494000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
43936000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-30698000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-44669000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7000
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
11000
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
7183000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-48000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-20000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-23556000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-44678000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-23566000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-44683000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23573000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44689000
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
231990998
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21704185
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
144231000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
823000
CY2022Q1 bgry Adjustments To Additional Paid In Capital Equity Reclassification Of Restricted Stock To Equity
AdjustmentsToAdditionalPaidInCapitalEquityReclassificationOfRestrictedStockToEquity
706000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4408000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-23566000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
126595000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
278000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1165000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-44683000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-177368000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-23566000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-44683000
CY2022Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
760000
CY2021Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
546000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-12000
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-13000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7183000
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
33000
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
8000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1838000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
-24179000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1962000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14176000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1249000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-221000
CY2022Q1 bgry Increase Decrease In Deferred Fulfillment Costs
IncreaseDecreaseInDeferredFulfillmentCosts
-13552000
CY2021Q1 bgry Increase Decrease In Deferred Fulfillment Costs
IncreaseDecreaseInDeferredFulfillmentCosts
558000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
129000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2365000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
348000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
466000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-553000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3114000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
16417000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-753000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-34000
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-26000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32238000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11216000
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
46000
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1194000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-46000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1194000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
822000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
278000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
822000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
278000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-46000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-15000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31508000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12147000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
171951000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94978000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
140443000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82831000
CY2022Q1 bgry Right Of Use Asset Non Cash And Non Financing Activities
RightOfUseAssetNonCashAndNonFinancingActivities
8154000
CY2022Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
10287000
CY2022Q1 us-gaap Line Of Credit Assumed1
LineOfCreditAssumed1
884000
CY2022Q1 bgry Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
147000
CY2021Q1 bgry Property Plant And Equipment Included In Accounts Payable And Accrued Expenses
PropertyPlantAndEquipmentIncludedInAccountsPayableAndAccruedExpenses
260000
CY2022Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
129172000
CY2021Q1 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
81239000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
139581000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81710000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
862000
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1121000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
140443000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82831000
CY2022Q1 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
227300000
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.44%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions which affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. These estimates and judgments include, but are not limited to, revenue recognition, realizability of deferred fulfillment costs, inventory, warranty cost, accounting for stock-based compensation (including performance-based assessments), and accounting for income taxes and related valuation allowances. Actual results may differ from estimates.</span></p>
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Concentration of Credit Risk and Significant Customers</span></p><p style="text-indent:4.44%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments which potentially expose the Company to concentrations of credit risk consist of accounts receivable and cash and cash equivalents.</span></p><p style="text-indent:4.44%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Sales of the Company’s products are concentrated among specific customers. At March 31, 2022, and December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">four</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> customers accounted for approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">100</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% of the Company’s accounts receivable balance, respectively. For the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three months ended March 31, 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, the Company generated </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">38</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">14</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">12</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% of revenues from </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">five</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> customers. For the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">three months ended March 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">, the Company generated approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">60</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">40</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">%</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">of revenues from </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> customers. The Company believes that credit risks associated with these contracts are not significant due to the customers’ financial strength.</span></p><p style="text-indent:4.44%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The Company places cash and cash equivalents with high-quality financial institutions. The Company is exposed to credit risk in the event of default by these institutions to the extent the amount recorded on the condensed consolidated balance sheets exceeds federally insured limits.</span></p>
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
82000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
538000
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3808000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8562000
CY2022Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
937000
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
372000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1149000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1742000
CY2022Q1 bgry Accrued Materials Current
AccruedMaterialsCurrent
8174000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2103000
CY2022Q1 us-gaap Inventory Net
InventoryNet
3890000
CY2021Q4 us-gaap Inventory Net
InventoryNet
2641000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14497000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15219000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5086000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4345000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9411000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10874000
CY2022Q1 us-gaap Depreciation
Depreciation
800000
CY2021Q1 us-gaap Depreciation
Depreciation
500000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2458000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15132000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15659000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
452000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
41000
CY2022Q1 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-94000
CY2021 us-gaap Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
-58000
CY2022Q1 bgry Warranty Costs Incurred During Period
WarrantyCostsIncurredDuringPeriod
22000
CY2021 bgry Warranty Costs Incurred During Period
WarrantyCostsIncurredDuringPeriod
469000
CY2022Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
380000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
452000
CY2021 us-gaap Loss On Contracts
LossOnContracts
12100000
CY2022Q1 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
8500000
CY2021Q4 us-gaap Provision For Loss On Contracts
ProvisionForLossOnContracts
8500000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5492000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3965000
CY2022Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
21200000
CY2021Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
7700000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19216000
CY2022Q1 bgry Contract Liabilities Incurred During The Period
ContractLiabilitiesIncurredDuringThePeriod
19871000
CY2022Q1 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
-674000
CY2022Q1 bgry Contract With Customer Liabilities Incurred During The Period Revenue Recognized
ContractWithCustomerLiabilitiesIncurredDuringThePeriodRevenueRecognized
-2780000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
35633000
CY2022Q1 bgry Public And Private Warrant Value Trading Price
PublicAndPrivateWarrantValueTradingPrice
410
CY2022Q1 bgry Fairvalueequitylevel1 Tolevel2 Tolevel3 Transfersamount
Fairvalueequitylevel1Tolevel2Tolevel3Transfersamount
0
CY2021Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
300000
CY2019Q4 us-gaap Related Party Transaction Rate
RelatedPartyTransactionRate
0.0186
CY2019Q4 bgry Relatedpartytransactionliablepercentage
Relatedpartytransactionliablepercentage
0.51
CY2022Q1 bgry Cumulative Amount Raised Redeemable Convertible Preferred Stock
CumulativeAmountRaisedRedeemableConvertiblePreferredStock
227300000
CY2022Q1 bgry Stockrepurchaseagreementdescription
Stockrepurchaseagreementdescription
On February 23, 2021, the Company entered into a Stock Repurchase Agreement with the executive officer. In the Stock Repurchase Agreement, the Company’s Board of Directors authorized the repurchase of a sufficient number of vested shares of common stock from the executive officer, at an aggregate price sufficient to repay the Promissory Note. At the Closing Date on July 21, 2021, all outstanding principal and accrued interest under the Promissory Note was repaid and the note was retired.
CY2019Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
9900000
CY2022Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
188353093
CY2022Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
165744062
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
165744062
CY2022Q1 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
239447000
CY2022Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
5.87585
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-1838000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24179000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3231432
CY2021Q1 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1023825
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
900000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9400000
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
CY2021Q1 bgry Income Tax Expense Benefit To Future Taxable Income
IncomeTaxExpenseBenefitToFutureTaxableIncome
0
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0005
CY2022Q1 us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
one-for-one
CY2022Q1 bgry Income Tax Expense Benefit To Future Taxable Income
IncomeTaxExpenseBenefitToFutureTaxableIncome
0
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q1 us-gaap Revenues
Revenues
5492000
CY2021Q1 us-gaap Revenues
Revenues
3965000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
986000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1462000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1504000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1473000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1287000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
5792000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12504000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2217000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
10287000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
300000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
200000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y6M
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045
CY2022Q1 us-gaap Property Subject To Or Available For Operating Lease Number Of Units
PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits
0
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
14750000
CY2022Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00

Files In Submission

Name View Source Status
0000950170-22-009646-index-headers.html Edgar Link pending
0000950170-22-009646-index.html Edgar Link pending
0000950170-22-009646.txt Edgar Link pending
0000950170-22-009646-xbrl.zip Edgar Link pending
bgry-20220331.htm Edgar Link pending
bgry-20220331.xsd Edgar Link pending
bgry-20220331_cal.xml Edgar Link unprocessable
bgry-20220331_def.xml Edgar Link unprocessable
bgry-20220331_htm.xml Edgar Link completed
bgry-20220331_lab.xml Edgar Link unprocessable
bgry-20220331_pre.xml Edgar Link unprocessable
bgry-ex31_1.htm Edgar Link pending
bgry-ex31_2.htm Edgar Link pending
bgry-ex32_1.htm Edgar Link pending
bgry-ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending